Author | Matthew Gavidia | OncLive

Author | Matthew Gavidia


US Biosimilar Portfolio Hits 10-Year Mark in Growth Mode

August 02, 2020

Since the US regulatory and litigation pathway for biosimilars was signed into law in March 2010, the FDA has approved 28 biosimilar products, including 16 drugs with indications for patients with cancer.